{"id":"W4415475778","doi":"10.1681/asn.2025ma7ztv7r","title":"Zanubrutinib (zanu) in Anti-Phospholipase A2 Receptor (PLA2R)-Associated Primary Membranous Nephropathy (PMN): Preliminary Results of a Phase 2/3, Multicenter, Randomized, Open-Label Study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Membranous nephropathy; Phase (matter); Receptor; Glomerulonephritis; Kidney; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002521343,0.0009342823,0.001804597,0.0002766947,0.0003492812,0.0006709555,0.0005157261,0.0006541468,0.002142758],"category_scores_gemma":[0.0008291103,0.0003371568,0.0008606911,0.0003727766,0.0005256798,0.0006172518,0.0002436546,0.001768988,0.0004282181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00069479,"about_ca_system_score_gemma":0.001134127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001197691,"about_ca_topic_score_gemma":0.005100707,"domain_scores_codex":[0.9995901,0.0002283702,0.00002819279,0.00003610087,0.00004157896,0.00007564054],"domain_scores_gemma":[0.9994124,0.0001399757,0.000143198,0.00003300848,0.00004508976,0.0002263323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.727475,0.03616358,0.01019885,0.002242184,0.002211917,0.00038815,0.0002274353,0.002758962,0.06157703,0.0002428802,0.00546077,0.1510532],"study_design_scores_gemma":[0.5942601,0.3659182,0.02816486,0.0001059935,0.001274379,0.0004923185,0.00006032637,0.001656649,0.004971212,0.0001597687,0.00290995,0.00002628877],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902896,0.005936976,0.0005389561,0.0004162224,0.00009159352,0.0009222316,0.0006170803,0.00008034605,0.001106834],"genre_scores_gemma":[0.9930027,0.003401246,0.001000251,0.0003958208,0.0001878329,0.000530024,0.0007354704,0.00001606651,0.0007305198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002521343,"threshold_uncertainty_score":0.01333427,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02678802100635685,"score_gpt":0.3572640821743265,"score_spread":0.3304760611679697,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}